R
NA interference (RNAi) is emerging as one of the most powerful technologies for sequence-specific suppression of genes and has potential applications ranging from functional gene analysis to therapeutics. [1] [2] [3] [4] [5] [6] [7] [8] Due to the relatively low immunogenic and oncologic effects, the development of nonviral delivery methods in vitro and in organisms is of considerable current interest. In recent years, a number of strategies have been developed based on liposomes, gold and silica nanoparticles (NPs), cationic and biodegradable polymers, and peptides. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] The delivery efficiency, however, remains low, especially under in vivo conditions. Another limitation shared by all the existing delivery technologies is the lack of an intrinsic signal for long-term and real-time imaging of siRNA transport and release. Such imaging could provide important information on rational design of siRNA carriers. Currently, organic fluorophores are used to label siRNA or the delivery vehicles, 13, 20, 21 but the photobleaching problem associated with essentially all organic dyes prevents long-term tracking of siRNAϪcarrier complexes. Similarly, electron-dense gold NPs are visible under transmission electron microscope (TEM) and provide the highest imaging resolution in fixed cells, but they do not allow realtime imaging of live cells.
In this context, the use of semiconductor quantum dots (QDs) to study siRNA delivery in cells and small animals should be an excellent choice because of QDs' intrinsic fluorescence and their unique optical properties (e.g., tunable emission, photostability, and brightness). Indeed, recent work by Bhatia and co-workers has used QDs for siRNA delivery and imaging, 22, 23 but the QD probes are either mixed with conventional siRNA delivery agents (Lipofectamine) 22 or external endosomal rupture compounds (e.g., chloroquine) for gene silencing activity, 23 significantly limiting their potential applications in vivo. Therefore, development of multifunctional QDs with integrated functionalities of cell binding and internalization, endosome escape, siRNA protection against enzyme activities, siRNA unpackaging (siRNAϪcarrier dissociation), and siRNA tracking is of urgent need. On the other hand, packaging these functionalities into single nanoparticles also represents a significant technological challenge.
Here, we report a new technology by combining QDs with another class of nanomaterial, amphipol, to solve the aforementioned problems. Amphipols are linear polymers with alternating hydrophilic and hydrophobic side chains. They are widely used for solubilizing integral membrane proteins and delivering them into cell lipid bilayers (Figure 1a) . [24] [25] [26] [27] [28] Unlike detergentbased micelles, amphipols belt around the *Address correspondence to xgao@u.washington.edu.
transmembrane domain of membrane proteins and do not disrupt the integrity of cell membrane during delivery. To our surprise, however, when amphipols are mixed with nanoparticles coated with hydrophobic surface ligands, these two types of nanomaterials form stable complexes that are not only capable of carrying siRNA molecules into cytoplasm but also protecting them from enzymatic degradation (Figure 1b ). In addition, the QDs should also provide a bright and stable fluorescent signal for intracellular siRNA imaging since great success has been achieved in the past 5 years in using QDs for cellular staining and imaging. [29] [30] [31] [32] [33] [34] The QDϪamphipol technology reported here will open new opportunities for traceable intracellular delivery of siRNA without the need of additional compounds.
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RESULTS AND DISCUSSION
In this report, we selected poly(maleic anhydride-alt-1-decene) modified with dimethylamino propylamine (PMAL, M w 18.5 K) because of its multiple useful properties (Figure 1c) . First, the hydrocarbons in PMAL bind to the hydrocarbons on the surface of QDs via multivalent hydrophobic interactions, leading to the formation of stable and water-soluble organicϪinorganic hybrid structures (Figure 1d) . Second, at neutral pH, the overall surface charge of the hybrid structure is highly positive, which allows immobilization of negatively charged biomolecules (e.g., siRNAs) and interaction with negatively charged cell surface. Previously, we and others have prepared amphiphilic copolymers for QD solublization and bioconjugation for cell labeling, 29, [36] [37] [38] but all those polymers employ a dense layer of carboxylic acids, which prevents interaction with siRNA molecules. Third, the clustered tertiary amines grafted on the PMAL backbone have strong proton absorbing capability inside acidic cellular compartments, such as endosomes, leading to osmotic swelling and endosome rupture. 16, [39] [40] [41] Besides the tertiary amines, it has also been shown that the pK a of carboxylic acid groups in polymaleic anhydrides is also around 5Ϫ6, resulting in a second chemical group for proton absorption. 42 Fourth, the coexistence of tertiary amine and carboxylic acid groups weakens the interaction between siRNA and nanoparticles, which is expected to facilitate siRNA release inside cells. Indeed, it has been found that, when polyethyleneimine (PEI) is chemically modified to reduce electrostatic binding, the gene delivery activity is increased by 20Ϫ60-fold. 43 Furthermore, the zwitterionic surface of QDϪPMAL could also become an important feature for in vivo applications because zwitterionic charge reduces serum protein adsorption onto NP surface, which not only slows NP uptake by the reticuloendothelial systems (RES) but also helps NP renal clearance when the particles are made smaller than 5.5 nm.
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The PMAL-encapsulated QDs were prepared by a molecular self-assembly approach. QDs coated with hydrophobic ligands (tri-n-octylphosphine oxide or TOPO) were mixed with PMAL at a molar ratio of 1:500. Because of the strong multivalent hydrophobic interactions between TOPO and the PMAL hydrocarbons, QD and PMAL bind to each other and form highly stable complexes (at least 6 months, Supplementary Figure  S1 ). Transmission electron microscopy (TEM), dynamic light scattering (DLS), and spectroscopy measurements were taken to thoroughly characterize the size and optical properties of purified QDϪPMAL and its siRNA complex. The PMAL-encapsulated QDs have excellent optical properties and narrow size distributions, with quantum yield values comparable to that of the original dots suspended in chloroform ( Figure 2a ). Dynamic light scattering measurements ( Figure 2b) shows that QDϪPMAL has a hydrodynamic diameter of 12.1 Ϯ 1.5 nm (1.5 nm is the standard deviation of three different samples, rather than the size spread in one sample). Considering the QD core is 5.5 Ϯ 0.7 nm in diameter (Figure 2c ), the larger hydrodynamic radius in aqueous buffers is likely due to the physical size of the positively charged PMAL polymer, as well as its strong interaction with the solvent. 46 This surface charge is sufficient to carry small oligonucleotides and deliver them into mammalian cells. When bound to siRNA, the size of the nanoparticle complexes further increases to 15.9 Ϯ 1.0 nm (1.0 nm is the standard deviation of three different samples), suggesting that QDs remain mainly single with siRNA on the surface, a result that was also confirmed by the "blinking" feature of QDs under fluorescence microscopy. The compact size of single particles is highly desirable because large particles enter cells at a much slower rate 47 and can be eliminated quickly by the RES system in vivo. 48 In contrast, previously reported gene deliveries based on silica and gold nanoparticles often form 100Ϫ200 nm aggregates likely because the size mismatch of large plasmid DNA to small nanoparticles, and consequently, it requires many NPs to work together (forming clusters with the DNA plasmid) for successful transfection. [10] [11] [12] [13] To investigate the number of siRNAs that can be loaded onto individual QDs, we labeled siRNA molecules with FITC dye (green) and mixed the siRNA (constant siRNA quantity at 10 pmol) with red QDs at various molar ratios. As shown in the gel electrophoresis data (Figure 3a) , the fluorescence intensity of the siRNA band gradually decreases as QD concentration increases and disappears when the siRNA/QD ratio is below 10, indicating that approximately 10 siRNA molecules can be immobilized onto the surface of individual QDs. To ensure this result is not an artifact due to the detection limit of gel electrophoresis, siRNAϪFITC samples of various quantity ranging from 10 to 0.1 pmol were also studied under similar experiment conditions. As shown in Supplementary Figure S2 , siRNA of 0.2 pmol is still detectable, suggesting that the disappearance of siRNA bands in the siRNA/QD ratio studies is indeed due to siRNAϪQD binding. Focused on the siRNA/QD ratio of 1:1, which is used in the siRNA intracellular delivery experiment described below, we conducted two additional assays to confirm siRNAϪQD association. First, -potential measurements show that QDϪPMAL has a -potential value of 21.3 mV before siRNA binding, and it reduces to 18.2 mV after siRNA binding because negatively charged siRNA partially neutralizes the positive charge on the QD surface. Second, the interaction of siRNA with QDs can also be characterized by fluorescence quenching of FITClabeled siRNA due to fluorescence resonance energy transfer or FRET (Supplementary Figure S3) . The association of siRNA to QDs provides a mechanism for siRNA protection against enzymatic degradation. This is a very important feature because RNAs, in general, are susceptible to nuclease digestion. Enhanced resistance to nuclease degradation should increase siRNA lifetime in the cell and the subsequent interference effect on target mRNAs. Gel electrophoresis experiments show that QD-bound siRNAs are degraded at a significantly slower rate (75% intact) compared with free siRNA (undetectable) under the same experiment conditions (Figure 3b ). Similar results have been previously observed with plasmid DNA and short oligonucleotides on silica and gold NPs and have been attributed to the NP steric hindrance to nuclease activities. [49] [50] [51] [52] [53] To evaluate the RNAi efficiency using QDϪPMAL delivery vehicle, a model gene silencing experiment was designed using human breast adenocarcinoma cell line (SK-BR-3) and siRNA targeting Her-2/neu. Her-2/neu, a cell surface receptor tyrosine kinase, is overexpressed in approximately 30% of breast tumors and is an excellent model system because it is involved in signal transduction pathways leading to cell growth and differentiation. Figure 4 shows that Her-2/neu expression was suppressed to 36 Ϯ 2% using QDϪPMAL in serum-free media. In comparison, when the two common transfection reagents (Lipofectamine and PEI) were used, the target gene expression was reduced to 29 Ϯ 5 and 58 Ϯ 13%, respectively. When used in complete cell culture media (contains serum), QDϪPMAL reduces Her-2 expression to 35 Ϯ 4%, similar to the values achieved with serum-free media. Lipofectamine and PEI reduce Her-2 expression to 48 Ϯ 7 and 62 Ϯ 5%. These results demonstrate that QDϪPMAL is efficient in siRNA intracellular delivery for both serum-free and complete media. In contrast, Lipofectamine only works well in serum-free media, and the QDϪPMAL also outperforms PEI under both conditions.
The high delivery efficiency of QDϪPMAL could be explained by its structural and surface properties. First, when complexes with siRNA form, QDs remain single, and the small sizes facilitate their diffusion and entry into cells. Second, after the nanostructures are endocytosed, both the tertiary amines and carboxylic groups on the QD surface play important roles in endosome escape. At low pH values, carboxylic and amine groups are protonated, and at high pH values, they will be deprotonated. Therefore, the zwitterionic surface behaves like a buffer system that can quickly neutralize excess protons in the endosome, which also leads to a net influx of chloride ions. The osmotic pressure building along this proton buffering process will eventually rupture the endosomes, a process known as "proton sponge effect". 16, [39] [40] [41] Owing to the intrinsic fluorescence of QDs, the intracellular behavior of QDϪsiRNA complexes, including cell entry, endosome escape, and transport, can be monitored in real time. Time-lapse confocal micros- copy ( Figure 5 ) shows that the QDϪsiRNA complexes attach to cell surface immediately after mixing with cells (a bright ring structure). Subsequent incubation over a period of 1 h allows the complexes to enter and accumulate inside cells (bright interior), suggesting efficient transport across the plasma membrane. During this period, only the QD fluorescence (red) is visible but not the siRNAϪFITC (green), indicating that siRNA and QDs are associated with each other (FITC is quenched due to FRET). The siRNA molecules started to separate from QDs as soon as 1.5 h (signal appeared in the green channel). More importantly, after 5 h incubation, siRNAs became evenly distributed in the cytoplasm, confirming the efficient endosome escape. It is also interesting to note that the QDs are not evenly distributed in the cytoplasm after endosome rupture. Instead, they form large clusters, likely due to aggregation with intracellular proteins and lipids. When this process was performed in vitro by acidifying the buffer to pH 5, siRNA and QDs remain single and bound, suggesting that inside cells siRNAs are likely replaced from QD surface by other biomolecules. It is also worth mentioning that the characteristic intermittent fluorescence of QDs does not interfere with fluorescence imaging in the current study because QDs are imaged in groups. After the QDϪsiRNAs enter cells through endocytosis, many copies of the complexes are confined in small endosomal compartments. Although individual QDs fluoresce in an on-and-off manner, the chance that multiple copies of QDs stay in the "dark" state simultaneously is extremely small. Collectively, QDs remain in the "bright" state at all time.
A remaining key question is whether QDϪPMAL as a new siRNA carrier is toxic to cells. This is a particularly important issue when the core nanoparticle is a semiconductor QD because it contains cadmium. However, our results show that QDs are nearly nontoxic to cells ( Figure 6 , whereas Lipofectamine and PEI reduce cell viability to 84 and 68%, respectively. The low toxicity of QDs is perhaps not surprising because the stable PMAL polymer coating layer protects QDs from being exposed to the intracellular environment and thereby prevents Cd 2ϩ release. Indeed, the QDs remain highly fluorescent even in acidic endosomes, indicating that the core QDs are intact. In contrast, when siRNA targeting Her-2 was used in the study, the QDϪsiRNA was found to be toxic to cells, demonstrated by a greater than 20% decrease in cell viability. This siRNA toxicity was minimal when scramble siRNA sequence was used. Similar result was also observed with Lipofectamine transfection. The cell death triggered by Her-2 siRNA also confirms successful gene silencing because Her-2 is involved in signaling pathways of cell growth and differentiation. It has been previously shown that knockdown of the Her-2/neu gene in SK-BR-3 cells inhibits cell proliferation and induces apoptosis. 54 We also noticed that the Her-2 siRNA toxicity and the level of Her-2 silencing only correlate qualitatively, indicating the Her-2 siRNA toxicity and Her-2 silencing may not have a linear relationship. Quantitative measurement of the Her-2 siRNA cotytoxicity effect deserves further investigation. For potential translational and clinical applications of this technology, the suitability of using QDs is difficult to predict at this time because the longterm (e.g., years) toxicity of QDs is largely unknown. However, it is also important to point out that the core particle is not limited to QDs for nanoparticleϪPMAL assembly. Traceable nanoparticles with non-or minimumtoxic chemical elements (such as silicon and iron oxides) can be used and encapsulated with PMAL using similar chemistry.
CONCLUSION
We have developed a new siRNA delivery technology by integrating two distinct types of nanomaterials, semiconductor QDs and amphipols. An important finding is that, although amphipols have found widespread uses in solubilizing and delivering hydrophobic proteins into the cell lipid bilayers, when combined with nanoparticles, they offer previously undiscovered functionalities, including siRNA cytoplasm delivery, siRNA protection, and endosome escape. Compared with the traditional siRNA carriers, such as Lipofectamine and PEI, this new class of nanocarrier delivers siRNA into cancer cells efficiently in both serum-free and complete media with significantly reduced cytotoxicity. Furthermore, the unique optical properties of QDs and exquisite design of imaging assays (such as FRET) allow realtime imaging of siRNA delivery in live cells. We envision that further development of this new multifunctional, compact, and traceable nanocarrier (such as incorporating a targeting probe) will enable new developments in siRNA discovery and delivery, functional genomics, gene therapy, as well as biophysical studies.
MATERIALS AND EXPERIMENTS
Unless specified, chemicals were purchased from SigmaAldrich (St. Louis, MO) and used without further purification. PMAL was purchased from Anatrace Inc. (Maumee, OH). The siRNA targeting Her-2, FITC-labeled siRNA targeting Her-2, and the control sequence were purchased from Ambion (Austin, TX). A UV-2450 spectrophotometer (Shimadzu, Columbia, MD) and a Fluoromax4 fluorometer (Horiba Jobin Yvon, Edison, NJ) were used to characterize the absorption and emission spectra of QDs. A tabletop ultracentrifuge (Beckman TL120) was used for nanoparticle purification and isolation. The dry and hydrodynamic radii of QDs were measured on a CM100 transmission electron microscope (Philips EO, Netherlands) and a nanoparticle size analyzer (NanoZS, Worcestershire, United Kingdom). Confocal fluorescence images were obtained with a confocal microscope (Zeiss LSM 510, Germany) equipped with DPSS, argon, and He/Ne lasers with lines at 405, 458, 488, 543, and 633 nm. Multicolor gel images were acquired with a macro-imaging system (Lightools Research, Encinitas, CA). For the cytotoxicity measurements based on MTT assay, a Tecan Safire 2 plate reader (Switzerland) was used.
Preparation and Characterization of QD؊PMAL Complex. Highly luminescent QDs were synthesized as previously described by Peng and co-workers. 55, 56 Briefly, CdO (1 mmol) was dissolved in 1 g of stearic acid with heating. After formation of a clear solution, a mixture of tri-n-octylphosphine oxide (TOPO, 5 g) and hexadecylamine (HDA, 5 g) was added as the reaction solvent, which was then heated to 250°C under argon for 10 min. The reaction temperature was briefly increased to 350°C, and equal molar Se was quickly injected into the hot solvent. The reaction immediately changed color to orange-red, indicating QD formation. The dots were refluxed for 10 min, and capping solution of 20 mM dimethlyzinc and hexamethyldisilathiane was slowly added to protect the CdSe core. The resulting QDs were cooled to room temperature and rinsed repeatedly with methanol and hexane mixture to remove free ligands. UV adsorption, fluorescence emission spectroscopy, TEM, and DLS were used for characterization of particle optical properties and sizes.
For QDϪPMAL complex preparation, 10 mg of PMAL was mixed with 1 nmol of QDs in chloroform. The solvent was then allowed to slowly dry in air, leading to the formation a thin film of QDϪPMAL complexes. The dried film was dissolved in 50 mM borate buffer (pH 8.5) with agitation or sonication. Free PMAL polymers (unbound polymers) were removed by ultracentrifugation (45 000 rpm for 50 min). The fluorescence absorption and emission, the nanoparticle dry size and dynamic radii, surface charge, and electrophoretic mobility of the resulting nanoparticles were measured.
siRNA Loading Capacity (Number of SIRNA per QD). FITC-labeled siRNA targeting Her-2 (10 pmol) was incubated for 20 min with QDs of 10, 1, 0.5, 0.33, 0.25, and 0.2 pmol to achieve QD/siRNA molar ratios of 1:1, 1:10, 1:20, 1:30, 1:40, and 1:50. Electrophoresis and fluorescence imaging were then used to separate and quantify the unbound siRNA. To probe the detection limit of the gel electrophoresis technique, siRNAs of various concentrations were also studied.
siRNA Protection by QDs. For siRNA stability studies, siRNAϪQD complexes (1 M) or siRNA alone were incubated with ribonuclease (25 ng, Fisher Scientific, Pittsburgh, PA). The enzyme digestion reaction was stopped at 30 min by inactivating the nuclease with ribonuclease inhibitor (Promega, Madison, WI). The siRNA molecules were then released from the surface of QDs using 1% SDS. Electrophoresis was again used to quantify the intact siRNAs.
In Vitro siRNA Delievery. The siRNA transfection was performed with QDϪPMAL and, for comparison, with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) and PEI (M w 25 kDa). Briefly, 5 ϫ 10 4 cells/well were plated into 24-well plates overnight to achieve 60Ϫ80% confluence. On the day of transfection, cultured cells were washed and preincubated for 40 min with Twenty picomoles of siRNA targeting Her-2/neu was diluted into 50 L of OptiMEM. For siRNA transfection with Lipofectamine, 1 L/well transfection reagent (following vendor's protocol) was diluted into 50 L of OptiMEM, incubated for 10 min at room temperature, and mixed with siRNA. The complexes were added into cell culture to reach a siRNA final concentration of 33 nM. For siRNA transfection with PEI, the same concentration of siRNA (33 nM) and an N/P ratio of 14 were used. For transfection with PMAL encapsulated QDs, 20 pmol of QDs and siRNA was mixed in OptiMEM (100 L), incubated for 20 min, and then added into cell culture media (500 L serum-free OptiMEM or complete RPMI) to achieve a final QDϪsiRNA concentration of 33 nM.
Immunoblotting. Transfected cells were lysed using RIPA lysis buffer containing 1% lgepal-630, 0.5% deoxycholate, 0.1% SDS, 1 mM PMSF, and 1 g/mL each of leupeptin, aprotinin, and pepstatin in phosphate buffered saline (PBS). After centrifugation, the supernatant of the cell lysate was collected and the protein was measured by the standard Bradford assay (Bio-Rad Laboratories, Inc., Hercules, CA). Equal amounts of protein were loaded and separated on 10% SDS-PAGE then transferred to nitrocellulose membranes and blocked with 5% milk blocking buffer for 2 h. The membrane was incubated with rabbit polyclonal antihuman Her-2/neu antibodies (Abcam, Cambridge, MA), washed in Tween-Tris buffered saline (TTBS: 0.1% Tween-20 in 100 mM Tris-CL [pH 7.5], 0.9% NaCl), and probed with HRP-linked labeled goat antirabbit secondary antibodies (Abcam, Cambridge, MA). The blot was developed using an ECL kit (Pierce, Rockford, IL). Digital chemiluminescent images of the membrane were recorded using KODAK Image Station 4000MM. ␤-Actin was probed in the same way (except the antibodies) as the protein loading control.
Cytotoxicity Evaluation. Standard MTT assay 57 was performed to determine the cytotoxicity of the transfection agents and their siRNA complexes. Briefly, cells were incubated with the transfection agents for 24 h, collected by trypsinization, counted, and plated at a density 20 000 cells/well in 96-well flat-bottomed microtiter plates (100 L of cell suspension/well). Each siRNA delivery agent was investigated with or without siRNA. The absorbance of the converted dye was measured at a wavelength of 570 nm. The experiments were repeated at least three times.
